Application of whole genome sequencing approaches to cancer
UK businesses and research organisations can apply for a share of up to £5.4 million. This is for projects involving the application of whole genome sequencing to analyse cancers. This funding is from the Industrial Strategy Challenge Fund.
Innovate UK, part of UK Research and Innovation, will invest up to £5.4 million. This is for innovation projects that use whole genome sequencing to analyse cancers. This competition is funded through the Industrial Strategy Challenge Fund.
The aim is to encourage the development of new approaches to targeted therapy based on the molecular signatures of cancers. Your project can develop new analytical methods or validate new targets using new and existing genomic data from cancers.
We will fund feasibility studies, industrial research and experimental development.
This competition closes at midday 12pm UK time on the deadline stated.
Feasibility projects must have total eligible costs between £50,000 and £100,000. Industrial research and experimental development projects must have total eligible costs of between £100,000 and £1 million.
- Competition opens: Monday 7 October 2019
- Competition closes: Wednesday 22 January 2020 12:00pm